Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction
Shmuel Gottlieb, MD* ,
Valentina Boyko, MSc*,
David Harpaz, MD*,
Hanoch Hod, MD, FACC*,
Miriam Cohen, BSc*,
Lori Mandelzweig, MPH*,
Zahi Khoury, MD ,
Shlomo Stern, MD, FACC ,
Solomon Behar, MD* for the Israeli Thrombolytic Survey Group
* Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, Israel
Heiden Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel. A complete list of the study participants appears in J Am Coll Cardiol 1996;28:150613

View larger version (33K):
[in a new window]
|
Figure 1 Thirty-day and three-year crude mortality rates by age subgroups (p for trend <0.0001, for both 30-day mortality and incremental three-year mortality rates).
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Three-year Kaplan-Meier cumulative survival curves for patients who underwent acute reperfusion and those who did not; differences were assessed by log-rank test; p = 0.0007.
|
|

View larger version (19K):
[in a new window]
|
Figure 3 Three-year Kaplan-Meier cumulative survival curves for patients who underwent acute reperfusion and those who did not by reason of exclusion (contraindication, unqualifying electrocardiogram [ECG], late arrival and other reasons).
|
|

View larger version (15K):
[in a new window]
|
Figure 4 Three-year Kaplan-Meier cumulative survival curves for patients with nonQ-wave acute myocardial infarction who underwent invasive coronary procedures (angiography, angioplasty or coronary artery bypass grafting, not including primary angioplasty) and those who did not; p = 0.002, by log-rank test.
|
|
|